Role of succinylation modification in central nervous system diseases

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Dec 28;50(12):2449-2457. doi: 10.11817/j.issn.1672-7347.2025.250226.ABSTRACTSuccinylation is a post-translational modification that occurs on lysine residues and is mediated by succinyl-CoA, an intermediate of the tricarboxylic acid (TCA) cycle. It can signi

M Mengke Gu

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial

Eur Stroke J. 2026 Apr 6;11(4):aakag033. doi: 10.1093/esj/aakag033.ABSTRACTINTRODUCTION: The Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) trial showed that recurrent events were significantly reduced among colchicine-adherent non-cardioembolic stroke pati

L Louise Maes

miR-34a targets MTUS1 to regulate cardiac fibrosis in rats

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026 Jan 28;51(1):60-72. doi: 10.11817/j.issn.1672-7347.2026.250600.ABSTRACTOBJECTIVES: Cardiac fibrosis is a common pathological feature during the progression of various cardiovascular diseases and is characterized by excessive deposition of extracellular matri

J Jiajia Hu

B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts

Immunol Rev. 2026 May;339(1):e70124. doi: 10.1111/imr.70124.ABSTRACTAtherosclerotic cardiovascular disease (ASCVD) is increasingly recognized not just as a lipid-driven disease, but as a complex interplay between vascular cells and the immune system. Accumulating evidence highlights a central, yet h

S Sophieke Lems

Estrogen replacement therapy and physical function in rheumatoid arthritis

Rheumatology (Oxford). 2026 Apr 24:keag197. doi: 10.1093/rheumatology/keag197. Online ahead of print.ABSTRACTOBJECTIVES: Postmenopausal women with rheumatoid arthritis (RA) experience worsening functional decline, independent of disease activity. Estrogen replacement therapy (ERT) has been proposed

E Elizabeth Mollard